Download PDF
Clin Colon Rectal Surg 2016; 29(02): 130-137
DOI: 10.1055/s-0036-1580732
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Enterocutaneous Fistula: Proven Strategies and Updates

Irena Gribovskaja-Rupp
1   Department of Surgery, University of Iowa, Iowa City, Iowa
,
Genevieve B. Melton
2   Division of Colon and Rectal Surgery, University of Minnesota, Minneapolis, Minnesota
› Author Affiliations
Further Information

Publication History

Publication Date:
26 May 2016 (online)

    Permissions and Reprints

Abstract

Management of enterocutaneous fistula represents one of the most protracted and difficult problems in colorectal surgery with substantial morbidity and mortality rates. This article summarizes the current classification systems and successful management protocols, provides an in-depth review of fluid resuscitation, sepsis control, nutrition management, medication management of output quantity, wound care, nonoperative intervention measures, operative timeline, and considerations, and discusses special considerations such as inflammatory bowel disease and enteroatmospheric fistula.

Keywords

enterocutaneous fistula - enteroatmospheric fistula - spontaneous closure - mortality - timeline
 

  • References

  • 1 Sitges-Serra A, Jaurrieta E, Sitges-Creus A. Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg 1982; 69 (3) 147-150
    CrossrefPubMedGoogle Scholar
  • 2 Schein M, Decker GA. Postoperative external alimentary tract fistulas. Am J Surg 1991; 161 (4) 435-438
    CrossrefPubMedGoogle Scholar
  • 3 Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. SurgClin North Am 1996; 76 (5) 1009-1018
    PubMedGoogle Scholar
  • 4 Lloyd DA, Gabe SM, Windsor AC. Nutrition and management of enterocutaneous fistula. Br J Surg 2006; 93 (9) 1045-1055
    CrossrefPubMedGoogle Scholar
  • 5 Haffejee AA. Surgical management of high output enterocutaneous fistulae: a 24-year experience. CurrOpinClinNutrMetab Care 2004; 7 (3) 309-316
    PubMedGoogle Scholar
  • 6 Martinez JL, Luque-de-Leon E, Mier J, Blanco-Benavides R, Robledo F. Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes. World J Surg 2008; 32 (3) 436-443 , discussion 444
    CrossrefPubMedGoogle Scholar
  • 7 Li J, Ren J, Zhu W, Yin L, Han J. Management of enterocutaneous fistulas: 30-year clinical experience. Chin Med J (Engl) 2003; 116 (2) 171-175
    PubMedGoogle Scholar
  • 8 Campos AC, Andrade DF, Campos GM, Matias JE, Coelho JC. A multivariate model to determine prognostic factors in gastrointestinal fistulas. J Am CollSurg 1999; 188 (5) 483-490
    PubMedGoogle Scholar
  • 9 Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ. An 11-year experience of enterocutaneous fistula. Br J Surg 2004; 91 (12) 1646-1651
    CrossrefPubMedGoogle Scholar
  • 10 Reber HA, Roberts C, Way LW, Dunphy JE. Management of external gastrointestinal fistulas. Ann Surg 1978; 188 (4) 460-467
    CrossrefPubMedGoogle Scholar
  • 11 Rahbour G, Gabe SM, Ullah MR , et al. Seven-year experience of enterocutaneous fistula with univariate and multivariate analysis of factors associated with healing: development of a validated scoring system. Colorectal Dis 2013; 15 (9) 1162-1170
    PubMedGoogle Scholar
  • 12 Erdmann D, Drye C, Heller L, Wong MS, Levin SL. Abdominal wall defect and enterocutaneous fistula treatment with the vacuum-assisted closure (V.A.C.) system. PlastReconstrSurg 2001; 108 (7) 2066-2068
    PubMedGoogle Scholar
  • 13 Evenson AR, Fischer JE. Current management of enterocutaneous fistula. J GastrointestSurg 2006; 10 (3) 455-464
    PubMedGoogle Scholar
  • 14 Schecter WP. Management of enterocutaneous fistulas. SurgClin North Am 2011; 91 (3) 481-491
    PubMedGoogle Scholar
  • 15 Martinez JL, Luque-de-León E, Ballinas-Oseguera G, Mendez JD, Juárez-Oropeza MA, Román-Ramos R. Factors predictive of recurrence and mortality after surgical repair of enterocutaneous fistula. J GastrointestSurg 2012; 16 (1) 156-163 , discussion 163–164
    PubMedGoogle Scholar
  • 16 Fazio VW, Coutsoftides T, Steiger E. Factors influencing the outcome of treatment of small bowel cutaneous fistula. World J Surg 1983; 7 (4) 481-488
    CrossrefPubMedGoogle Scholar
  • 17 Lévy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM, Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 1989; 76 (7) 676-679
    CrossrefPubMedGoogle Scholar
  • 18 Mawdsley JE, Hollington P, Bassett P, Windsor AJ, Forbes A, Gabe SM. An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas. Aliment PharmacolTher 2008; 28 (9) 1111-1121
    CrossrefPubMedGoogle Scholar
  • 19 Bleier JI, Hedrick T. Metabolic support of the enterocutaneous fistula patient. Clin Colon Rectal Surg 2010; 23 (3) 142-148
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Kaushal M, Carlson GL. Management of enterocutaneous fistulas. Clin Colon Rectal Surg 2004; 17 (2) 79-88
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Samad S, Anele C, Akhtar M, Doughan S. Implementing a pro-forma for multidisciplinary management of an enterocutaneous fistula: a case study. Ostomy Wound Manage 2015; 61 (6) 46-52
    PubMedGoogle Scholar
  • 22 Polk TM, Schwab CW. Metabolic and nutritional support of the enterocutaneous fistula patient: a three-phase approach. World J Surg 2012; 36 (3) 524-533
    CrossrefPubMedGoogle Scholar
  • 23 Schecter WP, Hirshberg A, Chang DS , et al. Enteric fistulas: principles of management. J Am CollSurg 2009; 209 (4) 484-491
    PubMedGoogle Scholar
  • 24 Datta V, Engledow A, Chan S, Forbes A, Cohen CR, Windsor A. The management of enterocutaneous fistula in a regional unit in the United Kingdom: a prospective study. Dis Colon Rectum 2010; 53 (2) 192-199
    CrossrefPubMedGoogle Scholar
  • 25 Dudrick SJ, Maharaj AR, McKelvey AA. Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg 1999; 23 (6) 570-576
    CrossrefPubMedGoogle Scholar
  • 26 Irving M, White R, Tresadern J. Three years' experience with an intestinal failure unit. Ann R CollSurgEngl 1985; 67 (1) 2-5
    PubMedGoogle Scholar
  • 27 Dellinger RP, Levy MM, Rhodes A , et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41 (2) 580-637
    CrossrefPubMedGoogle Scholar
  • 28 Davis KG, Johnson EK. Controversies in the care of the enterocutaneous fistula. SurgClin North Am 2013; 93 (1) 231-250
    PubMedGoogle Scholar
  • 29 Härle K, Lindgren M, Hallböök O. Experience of living with an enterocutaneous fistula. J ClinNurs 2015; 24 (15–16) 2175-2183
    PubMedGoogle Scholar
  • 30 Chapman R, Foran R, Dunphy JE. Management of intestinal fistulas. Am J Surg 1964; 108: 157-164
    CrossrefPubMedGoogle Scholar
  • 31 Makhdoom ZA, Komar MJ, Still CD. Nutrition and enterocutaneous fistulas. J ClinGastroenterol 2000; 31 (3) 195-204
    PubMedGoogle Scholar
  • 32 Singh R. Evaluation of nutritional status by different parameters and to predict spontaneous closure, morbidity, and mortality in patients with enterocutaneous fistulas: a study of 92 cases. The Internet J Nutrition Wellness 2007; 6 (1) 1-6
    PubMedGoogle Scholar
  • 33 Lu CY, Wu DC, Wu IC , et al. Serum albumin level in the management of postoperative enteric fistula for gastrointestinal cancer patients. J Invest Surg 2008; 21 (1) 25-32
    CrossrefPubMedGoogle Scholar
  • 34 Lubana PS, Aggarwal G, Aggarwal H, Jain DK. Serum transferrin levels – a predictive marker of spontaneous closure and mortality in patients with enterocutaneous fistulae. Arab J Gastroenterol 2010; 11 (4) 212-214
    CrossrefPubMedGoogle Scholar
  • 35 Teubner A, Morrison K, Ravishankar HR, Anderson ID, Scott NA, Carlson GL. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg 2004; 91 (5) 625-631
    CrossrefPubMedGoogle Scholar
  • 36 Deitel M. Elemental diet and enterocutaneous fistula. World J Surg 1983; 7 (4) 451-454
    CrossrefPubMedGoogle Scholar
  • 37 Hesse U, Ysebaert D, de Hemptinne B. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data. Gut 2001; 49 (Suppl. 04) iv11-iv21
    CrossrefPubMedGoogle Scholar
  • 38 Jenkins SA, Nott DM, Baxter JN. Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae. Eur J GastroenterolHepatol 1995; 7 (3) 255-258
    PubMedGoogle Scholar
  • 39 Paran H, Neufeld D, Kaplan O, Klausner J, Freund U. Octreotide for treatment of postoperative alimentary tract fistulas. World J Surg 1995; 19 (3) 430-433 , discussion 433–434
    CrossrefPubMedGoogle Scholar
  • 40 Sheppard M, Shapiro B, Pimstone B, Kronheim S, Berelowitz M, Gregory M. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. J ClinEndocrinolMetab 1979; 48 (1) 50-53
    PubMedGoogle Scholar
  • 41 Jamil M, Ahmed U, Sobia H. Role of somatostatin analogues in the management of enterocutaneous fistulae. J Coll Physicians Surg Pak 2004; 14 (4) 237-240
    PubMedGoogle Scholar
  • 42 Hernández-Aranda JC, Gallo-Chico B, Flores-Ramírez LA, Avalos-Huante R, Magos-Vázquez FJ, Ramírez-Barba EJ. [Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition]. NutrHosp 1996; 11 (4) 226-229
    PubMedGoogle Scholar
  • 43 Torres AJ, Landa JI, Moreno-Azcoita M , et al. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg 1992; 127 (1) 97-99 , discussion 100
    CrossrefPubMedGoogle Scholar
  • 44 Scott NA, Finnegan S, Irving MH. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study. ActaGastroenterolBelg 1993; 56 (3–4) 266-270
    PubMedGoogle Scholar
  • 45 Gayral F, Campion JP, Regimbeau JM , et al; Lanreotide Digestive Fistula. Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae. Ann Surg 2009; 250 (6) 872-877
    CrossrefPubMedGoogle Scholar
  • 46 Isenmann R, Schielke DJ, Morl FK , et al. Adjuvant therapy with somatostatin iv in postoperative fistulae of the pancreas, gall bladder and small intestine. A multicentre randomised study. Aktuelle Chirurgie 1994; 29: 96-99
    PubMedGoogle Scholar
  • 47 Spiliotis J, Vagenas K, Panagopoulos K, Kalfarentzos F. Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only. Br J ClinPract 1990; 44 (12) 616-618
    PubMedGoogle Scholar
  • 48 Sancho JJ, di Costanzo J, Nubiola P , et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995; 82 (5) 638-641
    CrossrefPubMedGoogle Scholar
  • 49 Leandros E, Antonakis PT, Albanopoulos K, Dervenis C, Konstadoulakis MM. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas. Can J Gastroenterol 2004; 18 (5) 303-306
    PubMedGoogle Scholar
  • 50 Coughlin S, Roth L, Lurati G, Faulhaber M. Somatostatin analogues for the treatment of enterocutaneous fistulas: a systematic review and meta-analysis. World J Surg 2012; 36 (5) 1016-1029
    CrossrefPubMedGoogle Scholar
  • 51 Rahbour G, Siddiqui MR, Ullah MR, Gabe SM, Warusavitarne J, Vaizey CJ. A meta-analysis of outcomes following use of somatostatin and its analogues for the management of enterocutaneous fistulas. Ann Surg 2012; 256 (6) 946-954
    CrossrefPubMedGoogle Scholar
  • 52 Galie KL, Whitlow CB. Postoperative enterocutaneous fistula: when to reoperate and how to succeed. Clin Colon Rectal Surg 2006; 19 (4) 237-246
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Brindle CT, Blankenship J. Management of complex abdominal wounds with small bowel fistulae: isolation techniques and exudate control to improve outcomes. J Wound Ostomy Continence Nurs 2009; 36 (4) 396-403
    CrossrefPubMedGoogle Scholar
  • 54 Wainstein DE, Fernandez E, Gonzalez D, Chara O, Berkowski D. Treatment of high-output enterocutaneous fistulas with a vacuum-compaction device. A ten-year experience. World J Surg 2008; 32 (3) 430-435
    CrossrefPubMedGoogle Scholar
  • 55 KCI Website. Available at: www.kci1.com . Accessed August 15, 2015
    PubMedGoogle Scholar
  • 56 Medeiros AC, Aires-Neto T, Marchini JS, Brandão-Neto J, Valença DM, Egito ES. Treatment of postoperative enterocutaneous fistulas by high-pressure vacuum with a normal oral diet. Dig Surg 2004; 21 (5–6) 401-405
    CrossrefPubMedGoogle Scholar
  • 57 Goverman J, Yelon JA, Platz JJ, Singson RC, Turcinovic M. The “Fistula VAC,” a technique for management of enterocutaneous fistulae arising within the open abdomen: report of 5 cases. J Trauma 2006; 60 (2) 428-431 , discussion 431
    CrossrefPubMedGoogle Scholar
  • 58 Ruiz-López M, Carrasco Campos J, Sánchez Pérez B, González Sánchez A, Fernández Aguilar JL, Bondía Navarro JA. [Negative pressure therapy in wounds with enteric fistulas]. Cir Esp 2009; 86 (1) 29-32
    CrossrefPubMedGoogle Scholar
  • 59 Cro C, George KJ, Donnelly J, Irwin ST, Gardiner KR. Vacuum assisted closure system in the management of enterocutaneous fistulae. Postgrad Med J 2002; 78 (920) 364-365
    CrossrefPubMedGoogle Scholar
  • 60 Rao M, Burke D, Finan PJ, Sagar PM. The use of vacuum-assisted closure of abdominal wounds: a word of caution. Colorectal Dis 2007; 9 (3) 266-268
    CrossrefPubMedGoogle Scholar
  • 61 Fischer JE. A cautionary note: the use of vacuum-assisted closure systems in the treatment of gastrointestinal cutaneous fistula may be associated with higher mortality from subsequent fistula development. Am J Surg 2008; 196 (1) 1-2
    CrossrefPubMedGoogle Scholar
  • 62 Avalos-González J, Portilla-deBuen E, Leal-Cortés CA , et al. Reduction of the closure time of postoperative enterocutaneous fistulas with fibrin sealant. World J Gastroenterol 2010; 16 (22) 2793-2800
    CrossrefPubMedGoogle Scholar
  • 63 Rábago LR, Ventosa N, Castro JL, Marco J, Herrera N, Gea F. Endoscopic treatment of postoperative fistulas resistant to conservative management using biological fibrin glue. Endoscopy 2002; 34 (8) 632-638
    Article in Thieme ConnectPubMedGoogle Scholar
  • 64 Lippert E, Klebl FH, Schweller F , et al. Fibrin glue in the endoscopic treatment of fistulae and anastomotic leakages of the gastrointestinal tract. Int J Colorectal Dis 2011; 26 (3) 303-311
    CrossrefPubMedGoogle Scholar
  • 65 Winder JS, Pauli EM. Comprehensive management of full-thickness luminal defects: the next frontier of gastrointestinal endoscopy. World J GastrointestEndosc 2015; 7 (8) 758-768
    PubMedGoogle Scholar
  • 66 Lyon JW, Hodde JP, Hucks D, Changkuon DI. First experience with the use of a collagen fistula plug to treat enterocutaneous fistulas. J VascIntervRadiol 2013; 24 (10) 1559-1565
    PubMedGoogle Scholar
  • 67 Lynch AC, Delaney CP, Senagore AJ, Connor JT, Remzi FH, Fazio VW. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg 2004; 240 (5) 825-831
    CrossrefPubMedGoogle Scholar
  • 68 Runström B, Hallböök O, Nyström PO, Sjödahl R, Olaison G. Outcome of 132 consecutive reconstructive operations for intestinal fistula—staged operation without primary anastomosis improved outcome in retrospective analysis. Scand J Surg 2013; 102 (3) 152-157
    CrossrefPubMedGoogle Scholar
  • 69 Subramaniam MH, Liscum KR, Hirshberg A. The floating stoma: a new technique for controlling exposed fistulae in abdominal trauma. J Trauma 2002; 53 (2) 386-388
    CrossrefPubMedGoogle Scholar
  • 70 Evans JP, Steinhart AH, Cohen Z, McLeod RS. Home total parenteral nutrition: an alternative to early surgery for complicated inflammatory bowel disease. J GastrointestSurg 2003; 7 (4) 562-566
    PubMedGoogle Scholar
  • 71 Present DH, Rutgeerts P, Targan S , et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340 (18) 1398-1405
    CrossrefPubMedGoogle Scholar
  • 72 Bor R, Farkas K, Bálint A , et al. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneousfistulizing Crohn's disease—clinical observations from a tertiary Eastern European center. Scand J Gastroenterol 2015; 50 (2) 182-187
    CrossrefPubMedGoogle Scholar
  • 73 Amiot A, Setakhr V, Seksik P , et al. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID. Am J Gastroenterol 2014; 109 (9) 1443-1449
    CrossrefPubMedGoogle Scholar
  • 74 Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum 2002; 45 (6) 771-775
    CrossrefPubMedGoogle Scholar